3 completed, 2 unknown, 1 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Unknown 2, Recruiting 1 |
Follow Purinergic P2Y Receptor Antagonists: new trials by email Literature Review of Purinergic P2Y Receptor Antagonists trials Research Report on Purinergic P2Y Receptor Antagonists
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-inflammatory Therapy for Recurrent In-stent Restenosis Colchicine, Prednisone, Aspirin - In-stent Restenosis | Phase 4 | Recruiting | Fu Wai Hospital, Beijing, China | 252 | 2023-10-30 | 2025-08-08 |
| DUAL Antithrombotic Therapy in Patients With AF and ACS Rivaroxaban 15 MG Oral Tablet, Clopidogrel 75 Mg Oral Tablet, Ticagrelor 90 MG Oral Tablet - Atrial Fibrillation, Acute Coronary Syndromes | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 4000 | 2019-10-01 | 2019-07-17 |
| Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis 12 months of P2Y12 receptor antagonist, 24 months of P2Y12 receptor antagonist, Aspirin - Percutaneous Coronary Intervention | Phase 4 | Unknown | Beijing Anzhen Hospital | 1000 | 2013-01-01 | 2015-03-30 |
| PROMUS Element Plus US Post-Approval Study PROMUS Element Plus Coronary Stent System, Aspirin, P2Y12 antagonist - Coronary Artery Disease | Phase 4 | Completed | Boston Scientific Corporation | 2681 | 2012-05-01 | 2018-07-26 |
| Ranitidin Versus Omeprazole in Patients Taking Clopidogrel omeprazole, Ranitidine, Clopidogrel - Coronary Artery Disease, Drug Interaction Potentiation | Phase 4 | Completed | University of Sao Paulo General Hospital | 92 | 2011-10-01 | 2018-07-06 |
| Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention clopidogrel treatment after bare metal stent implantation, clopidogrel after zotarolimus-eluting stent implantation, clopidogrel after paclitaxel-eluting stent implantation - Coronary Artery Disease | Phase 4 | Completed | Marco Valgimigli | 1700 | 2006-12-01 | 2012-10-10 |
Coronary Artery Disease (3) · Acute Coronary Syndrome (1) · Atherosclerosis (1) · Atrial Fibrillation (1)
Beijing Anzhen Hospital (1) · Boston Scientific Corporation (1) · Fu Wai Hospital, Beijing, China (1) · Marco Valgimigli (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University of Sao Paulo General Hospital (1)
China (2) · Italy (1) · United States (1)
Haiyan Qian (1) · Jun Jiang, PhD (1) · Marco Valgimigli, MD, PhD (1) · Peter M Maurer, MPH (1) · Yujie Zhou, MD, PhD (1)
PMID 21095265, PMID 22438530, PMID 23315904, PMID 24161321, PMID 24332420, PMID 25718355, PMID 26342472, PMID 26643501, PMID 26732420, PMID 26995375, PMID 27289472, PMID 27572001, PMID 28605779, PMID 29275371, PMID 33636137, PMID 35224730, PMID 37354778, PMID 41145262